序号 |
标题 |
次数 |
作者 |
发布时间 |
84466 |
氮桥连1,2,4,5-四嗪、呋咱、1H-四唑类多杂环化合物 |
154 |
WYQ |
2024-11-28 |
84467 |
DOTA-C-glyco-RGD , C-糖基化合物连接DOTA螯合剂 |
101 |
kx |
2024-11-28 |
84468 |
壳聚糖键接β-环糊精微球 CS-β-CD |
86 |
h |
2024-11-28 |
84469 |
DOTA-SA , DOTA-方酸 |
270 |
kx |
2024-11-28 |
84470 |
BKT140CXCR4 antagonist-DOTA |
156 |
zyl |
2024-11-28 |
84471 |
聚乙烯亚胺-聚乙二醇/α-环糊精空心微球 PEI-b-mPEG/α-CD |
114 |
h |
2024-11-28 |
84472 |
(LLP2A-DOTA)(2)PEG(10000) |
149 |
kx |
2024-11-28 |
84473 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
103 |
zyl |
2024-11-28 |
84474 |
P(Allyl-β-CD)/PSA微球 |
117 |
h |
2024-11-28 |
84475 |
LLP2A-DOTA; LLP2A-1,4,7,10-四氮杂环十二烷-N,N ',N ' ',N ' '-四乙酸 |
108 |
kx |
2024-11-28 |
84476 |
1,4-二氢-3,6-二取代-1,4-双(对甲苯磺酰基)-1,2,4,5-四嗪化合物 |
99 |
WYQ |
2024-11-28 |
84477 |
盐酸小檗碱犀-环糊精微球 BH-β-CDP |
112 |
h |
2024-11-28 |
84478 |
3,6-二硝氨基-1,2,4-三唑-[4,3-b][1,2,4,5]四嗪(NATZ) |
153 |
WYQ |
2024-11-28 |
84479 |
Gd(III)-DOTA/蛋白质笼纳米颗粒缀合物 |
140 |
kx |
2024-11-28 |
84480 |
壳聚糖/卵磷脂/β-环糊精微球 β-CD/PC/CS |
116 |
h |
2024-11-28 |
84481 |
3,6-二硝基-1,2,4-三唑-[4,3-b][1,2,4,5]四嗪(BNTZ) |
114 |
WYQ |
2024-11-28 |
84482 |
α-环糊精修饰纳米SiO2微球 α-CD-SiO2 |
160 |
h |
2024-11-28 |
84483 |
四唑并-[1,5-b]-1,2,4,5-四嗪和1,2,4-三唑并-[4,3-b]-1,2,4,5-四嗪稠环衍生物 |
160 |
WYQ |
2024-11-28 |
84484 |
CAS:1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
188 |
zyl |
2024-11-28 |
84485 |
3,3’-偶氮-1,2,4,5-四嗪衍生物 |
215 |
WYQ |
2024-11-28 |
84486 |
DOTA4-DO3A3复合物 ,DOTA4偶联DO3A3 |
138 |
kx |
2024-11-28 |
84487 |
多孔淀粉-环糊精基青蒿素微球(AHPS) |
212 |
h |
2024-11-28 |
84488 |
β-环糊精琼脂凝胶微球 AG-β-CD |
125 |
h |
2024-11-28 |
84489 |
CAS号:2389064-47-3 DOTA-tris(TBE)-amido-dPEG4-TFP ester |
126 |
zyl |
2024-11-28 |
84490 |
β-环糊精/碳微球复合材料 β-CD/CMSs |
176 |
h |
2024-11-28 |
84491 |
DOTA-二膦酸盐缀合的PSMA抑制剂 , DOTA-BP-PSMA |
95 |
wy |
2024-11-28 |
84492 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz) |
139 |
WYQ |
2024-11-28 |
84493 |
p-NH2-Bn-DOTA-四叔丁酯 |
94 |
zyl |
2024-11-28 |
84494 |
CAS号:213187-44-1 DOTA-BIM-23014:DOTA-Lanreotide |
131 |
zyl |
2024-11-28 |
84495 |
s-四嗪类衍生物:3-[(对硝基苯基)亚甲基腙]-6-(3,5-二甲基吡唑-1-基)-s-四嗪(DPHX) |
128 |
WYQ |
2024-11-28 |
84496 |
3,6-双[3-(2,2,2-三硝基乙基氨基-1,2,5-呋咱-4-基氨基]-1,2,4,5-四嗪(BTOAT) |
105 |
WYQ |
2024-11-28 |
84497 |
5-羧基四甲基罗丹明(TAMRA)荧光类似物TAMRA-K-A9 |
378 |
kx |
2024-11-28 |
84498 |
DOTA-cyclo(RGDfK) acetate |
150 |
zyl |
2024-11-28 |
84499 |
3,6-双(3-氨基-1,2,5-噁二唑-4-基氨基)-1,2,4,5-四嗪(BOAT) |
99 |
WYQ |
2024-11-28 |
84500 |
3,6-二氨基-1,2,4-三唑-[4,3-b][1,2,4,5]四嗪(AATZ) |
118 |
WYQ |
2024-11-28 |
84501 |
3-(2-丁基-5-氯-1H-咪唑-4-亚甲基腙)-6-(3,5-二甲基吡唑-1-基)-s-四嗪(BHT) |
116 |
WYQ |
2024-11-28 |
84502 |
白藜芦醇/羟丙基-β-环糊精/壳聚糖缓释微球 RES/HP-β-CD/Chitosan |
198 |
h |
2024-11-28 |
84503 |
CAS号:149819-85-2,Iron DOTA Sodium Salt |
113 |
zyl |
2024-11-28 |
84504 |
甘露糖修饰的β-环糊精丙酸酯(MCC) |
113 |
h |
2024-11-28 |
84505 |
N-氧化物修饰1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
131 |
kx |
2024-11-28 |
84506 |
Ga-DOTA-TOC acetate,CAS号:293295-70-2 |
143 |
zyl |
2024-11-28 |
84507 |
3,6-二-(2-丁基-5-氯-1H-咪唑-4-亚甲基腙)-s-四嗪(BBHT) |
154 |
WYQ |
2024-11-28 |
84508 |
DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
136 |
zyl |
2024-11-28 |
84509 |
Tb-DOTA ,铽-DOTA配合物 |
174 |
kx |
2024-11-28 |
84510 |
左氧氟沙星/γ-环糊精接枝壳聚糖纤维 Levofloxacin/β-CD-CS |
169 |
h |
2024-11-28 |